Fidelity Advisor Biotechnology A FBTAX
48.07 USD +1.26 (+2.69%)
At close·Nov 6, 2026, 8:08 PM EST
Day range unavailable
35.64 52-week range 52.27
- YTD
- +28.39%
- 1 year
- +38.65%
Altman Z-Score
13.67 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
8 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 8.0×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA 0.2×
EV/Sales 0.0×
FCF Yield 0.0%
Gross Margin 54.5%
Operating Margin 13.6%
Net Margin 10.9%
ROE 40.7%
ROIC 27.9%
ROA 19.4%
Revenue 3.9%
Operating Income 5.7%
EPS (diluted) 15.9%
Free Cash Flow 36.8%
Current Ratio 1.5×
Quick Ratio 0.8×
Debt / Equity 0.4×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 41.8%
Annual · latest fiscal year ends 2024-02-03